Home  >  Products  >  IL16 (interleukin 16 ) Blocking Peptide (the N terminal of IL16)(100ug)
IL16 (interleukin 16 ) Blocking Peptide (the N terminal of IL16)(100ug)

IL16 (interleukin 16 ) Blocking Peptide (the N terminal of IL16)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IL16 Antibody (ARP61283_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61283
Size: 100ug
Weight: 50kDa
Gene: 3603
Format: Lyophilized powder
Target: The protein encoded by this gene is a pleiotropic cytokine that functions as a chemoattractant, a modulator of T cell activation, and an inhibitor of HIV replication. The signaling process of this cytokine is mediated by CD4. The product of this gene undergoes proteolytic processing, which is found to yield two functional proteins. The cytokine function is exclusively attributed to the secreted C-terminal peptide, while the N-terminal product may play a role in cell cycle control. Caspase 3 is reported to be involved in the proteolytic processing of this protein. Alternate splicing results in multiple transcript variants.
Alternative names: LCF, NIL16, PRIL16, prIL-16